4
Changes in Ownership
CG Oncology, Inc. Filed Acc 0001415889-24-002062
10% owner bought 400,000 shares at $19.00 ($7,600,000)
- 10% owner acquired 3,628,198 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Decheng Capital Global Life Sciences Fund IV, L.P. · 10% owner
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-29 | Conversion : show line 1 in the form | +3,628,198 | 4,558,812 | D | ||
| 2024-01-29 | Purchase : show line 2 in the form | +400,000 | $19.00 | $7,600,000 | 400,000 | I |
| Open-market purchases · 400,000 sh · avg $19.00 · $7,600,000 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-01-29 | Conversion : show line 3 in the form Series C Preferred Stock | −8,644,891 | 0 | D |
| 2024-01-29 | Conversion : show line 4 in the form Series E Preferred Stock | −21,547,685 | 0 | D |
| 2024-01-29 | Conversion : show line 5 in the form Series F Preferred Stock | −4,402,320 | 0 | D |
Loading xslF345X05/form4-01312024_090105.xml…